November 30, 2018

Ned Milenkovich, co-chair of the firm's Health Care practice, moderated a Pharmacy Times program on the pathophysiology and outcomes of Alzheimer's disease (AD). Panelists discussed disease-modifying treatments for AD and how managed care organizations can successfully integrate these therapies as part of patients' disease management plans.

The program is available on the Pharmacy Times Continuing Education website. It is approved for 1.5 contact hours under the ACPE Universal Activity Number 0290-0000-18-228-H01-P. The activity is available until November 30, 2019.

This article contains material of general interest and should not be construed as legal advice or a legal opinion on any specific facts or circumstances. Under applicable rules of professional conduct, this content may be regarded as attorney advertising.

Publication Name
Pharmacy Times